🇺🇸 FDA
Pipeline program

Interleukin-2

LBo

Unknown small_molecule active

Quick answer

Interleukin-2 for Beta Thalassemia Major is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Beta Thalassemia Major
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials